The SCAA identifies and unites cardiac arrest survivors, those at risk of Sudden Cardiac Death, and those interested in advocating for SCAA issues in their communities and beyond.
David H. Fater
President, Chief Executive Officer, Chief Financial Officer, Director
Joining Vicor in 2002, David H. Fater also serves as Chief Executive Officer of ALDA & Associates International Inc., a business and financial consulting firm specializing in healthcare and life sciences.
Prior to forming ALDA & Associates in 1993, Mr. Fater was Chief Financial Officer of Vector Medical Technologies, Incorporated (2000-2002). Earlier, he held senior executive positions with three public healthcare companies. He led the initial public offering process for BMJ Medical Management, Inc. (1997-1999) and Community Care of America (1995-1996), and led Coastal Physician Group, Inc. (1993-1995) to a NYSE listing and $1 billion market capitalization. Before this, Mr. Fater was employed by Ernst & Young, where he completed his 24-year tenure as a Senior International Partner advising senior management and boards of directors (1969-1992).
Mr. Fater is a certified public accountant in Georgia, Illinois, North Carolina, and New York. He holds a BS in Accounting from the University of North Carolina.
James E. Skinner, Ph.D.
Vice President, Director of Grant Research, Director
Joining Vicor in August, 2000, Dr. Skinner has extensive experience both as a scientist and manager of large research and development projects. He is the Director of the Delaware Water Gap Science Institute, a non-profit medical research organization devoted to the development of medical devices and pharmaceuticals. Prior to founding the Delaware Water Gap Science Institute, Dr. Skinner was Associate Director of the Totts Gap Medical Research Laboratories, Inc. (1969-1997). Earlier, he was a Professor and Researcher at Baylor College of Medicine in Houston (1969-1993) and recipient of numerous research grants from the National Institutes of Health.
Dr. Skinner holds a PhD in Neuroscience from the University of California at Los Angeles and a BA in Pre-Med, Physics, and Physiological Psychology from Pomona College.
Jerry M. Anchin, Ph.D.
Vice President, Director of Research and Development, Director
Dr. Anchin has more than 30 years of experience in the fields of immunology, molecular biology, drug discovery and protein chemistry. Prior to joining Vicor in 2000, Dr. Anchin was employed by Ciblex Pharmaceuticals (1998-2000), where he became group leader of the drug discovery program that led to the discovery of novel small molecules for use in the prevention of asthma. Earlier, he held positions at Prism Pharmaceuticals (1996-1998), and Immuno Pharmaceuticals (1993-1996). Before that, he was Head of Assay Development and Manufacturing at International Immunoassay Labs (1991-1998), where he was instrumental in designing a novel assay for the detection of the protein creatine kinase released during acute myocardial infarction.
Dr. Anchin holds patents for 14 immunoassay and drug discovery platforms; he has an additional 16 patents pending. Dr. Anchin earned a PhD in Immunology from Texas A&M University and a BA in Cell Biology from the University of California at Santa Barbara.
Daniel N. Weiss, M.D., F.A.C.C.
Chief Medical Officer
With Vicor since 2004, Dr. Weiss has extensive experience as a practicing cardiologist and electrophysiologist. He is a partner in Florida Arrhythmia Consultants and a director of the Jim Moran Heart and Vascular Center (1994-present). He is also a consultant to several Fortune 500 medical device companies, including Medtronics, St. Jude Medical and Guidant. In addition, he served as clinical investigator in the MADIT-II (MultiCenter Automatic Defibrillator Implantation Trial) and SCDHeFT (Sudden Cardiac Death Heart Failure Trial) clinical trials.
Dr. Weiss received his MD with Distinction in Research from the Mount Sinai School of Medicine where he received the Nathan A. Setz Award for research in Cardiovascular and Renal Disease. He holds a BSE cum laude in Electrical Engineering and Computer Science from Princeton University.
Thomas J. Bohannon
Chief Accounting Officer
Thomas J. Bohannon was appointed to serve as the Chief Accounting Officer of the Company effective as of December 28, 2008. Mr. Bohannon has been in the accounting and financial field for more than 40 years. Mr. Bohannon worked as a senior manager at Ernst & Young in Atlanta from 1968 until 1978 where he specialized in financial and SEC reporting before becoming the partner in charge of audit and review services for Pappadakis, Nelson & Bohannon from 1978-1991. Since 1992, he has focused on his own consulting practice, serving as the financial officer for a variety of companies in the Southeast United States.
Lloyd C. Chesney
Chief Technology Officer
Lloyd C. Chesney was appointed Chief Technology Officer effective as of January 1, 2010. Mr. Chesney brings more than 20 years of healthcare IT exprience to Vicor. Prior to joining Vicor, he was CTO of MDVIP, the premier concierge physician organization providing personalized preventive medicine. During his tenure, he integrated MDTablet's electronic medical record into MDVIP's portal to provide bi-directional information exchange creating a dynamic patient health record, and integrated MDVIP's patient medical history into MDVIP's portal and MDTablet's electronic medical record for patient health risk assessments, which formed the foundation for individualized patient wellness plans.
An associate faculty member in Environmental Engineering of the University of Florida, Mr. Chesney is a recognized IT expert in the healthcare industry. He has made numerous presentations about the use of the internet, intranet, and networking technologies before prestigious medical associations including the Healthcare Information and Management Systems Society and the American College of Physicians. Specifically relevant to his work with Vicor, Mr. Chesney developed and deployed the first trauma/EMS tablet-based EMR system for use by field personnel.
Michael Harwitz
Senior Systems Architect
Michael Haritz was appointed as Senior Systems Architect effect as of January 1, 2010. Mr. Harwitz brings more than 15 years of experience leading IT integration and workflow automation processes to Vicor. Most recently, Mr. Harwitz provided Medical Data Group, Inc. a provider of digital medical records management and solution, with proprietary product development services. Earlier, he was Director, Application Development and Director, IT Strategic Development for Network for Medical Communication & Research, a leading provider of physician-accredited continuing medical eduation and analytical research for the oncology market.
